With the presidential campaign a month away, the Chinese Nationalist Party (KMT) released declassified documents related to Yu Chang Biologics, now known as TaiMed Biologics, alleging that Democratic Progressive Party (DPP) presidential candidate Tsai Ing-wen (蔡英文), in her capacity as vice premier, had approved the company’s establishment in 2007 mere months before resigning and taking up a position as the company’s chair, and so is suspected of having profiteered from the firm. The Yu Chang case has been sitting around for more than three years; that it has been resuscitated so close to the election reeks of political games.
Council for Economic Planning and Development Minister Christina Liu (劉憶如) has made clear there are no allegations of unlawful conduct in the Yu Chang case, but that there had been some procedural irregularities. This, she said, made it a political issue, as opposed to a legal one.
The first of these irregularities involved making certain documents classified, the most significant being when Academia Sinica president Wong Chi-huey (翁啟惠) invited scientific experts in the field to participate in the preparatory stages of a biotechnology company, and kept documents classified to maintain the confidentiality of those involved. The second revolves around two other classified documents, one of which was sent to then-premier Su Tseng-chang (蘇貞昌) and Tsai for approval, and the second of which was sent only to Tsai.
According to Ho Mei-yueh (何美玥), who at the time was with the council and responsible for the investment case, the first document needed to be handed to the Cabinet for review and approval at the most senior level, but that the second document was merely a report on the progress of the negotiations and only needed to be seen by the vice premier.
The next question concerned whether Tsai broke the “revolving door” clause about officials and private sector work. The National Development Fund is operated by the council, with the Cabinet playing a supervisory role. Yu Chang was not directly connected with the Cabinet, so there was no violation of the law here, either.
Finally, there is the allegation that Tsai’s family profited from involvement in the Yu Chang case. When Liu initially said that TaiMed Group was the same as “Taimao,” the company started up by Tsai and her family, it was a case of the council getting its chronology wrong by confusing Taimao with TaiMed Biologics. Taimao predated TaiMed Biologics — not TaiMed Group — and was set up by Tsai and her family as an investment company after Tsai had agreed in August 2007 to join the TaiMed Group negotiating team. The idea was that the family would first invest in Taimao and that Taimao would invest in Yu Chang, leaving the way open for other private funds to invest as well. The Tsai family withdrew a year after Yu Chang was established, retaining only their original investment and the interest on it, to the tune of more than NT$10 million (US$330,600).
The KMT has said Yu Chang stocks lost half their value, trading at NT$5 each, hinting that this was a failed investment, perhaps even fraud. However, biotech firms require long periods of investment to carry them through the protracted process of developing, patenting and formally marketing products before the company can start turning a profit.
Meanwhile, TaiMed Biologics traded at NT$32 a share last week.
The KMT is stopping at nothing to get votes. Even meddling in the Yu Chang case using erroneous data is not beneath it and this is something that will not go unnoticed in the scientific community. Scientists such as Wong, David Ho (何大一), Chen Yuan-tsong (陳垣崇) and Patrick Yang (楊育民) have international standing and the KMT’s actions may well drive them to support Tsai. It looks like the KMT might have shot itself in the foot.
Xiaomi Corp founder Lei Jun (雷軍) on May 22 made a high-profile announcement, giving online viewers a sneak peek at the company’s first 3-nanometer mobile processor — the Xring O1 chip — and saying it is a breakthrough in China’s chip design history. Although Xiaomi might be capable of designing chips, it lacks the ability to manufacture them. No matter how beautifully planned the blueprints are, if they cannot be mass-produced, they are nothing more than drawings on paper. The truth is that China’s chipmaking efforts are still heavily reliant on the free world — particularly on Taiwan Semiconductor Manufacturing
Keelung Mayor George Hsieh (謝國樑) of the Chinese Nationalist Party (KMT) on Tuesday last week apologized over allegations that the former director of the city’s Civil Affairs Department had illegally accessed citizens’ data to assist the KMT in its campaign to recall Democratic Progressive Party (DPP) councilors. Given the public discontent with opposition lawmakers’ disruptive behavior in the legislature, passage of unconstitutional legislation and slashing of the central government’s budget, civic groups have launched a massive campaign to recall KMT lawmakers. The KMT has tried to fight back by initiating campaigns to recall DPP lawmakers, but the petition documents they
A recent scandal involving a high-school student from a private school in Taichung has reignited long-standing frustrations with Taiwan’s increasingly complex and high-pressure university admissions system. The student, who had successfully gained admission to several prestigious medical schools, shared their learning portfolio on social media — only for Internet sleuths to quickly uncover a falsified claim of receiving a “Best Debater” award. The fallout was swift and unforgiving. National Yang Ming Chiao Tung University and Taipei Medical University revoked the student’s admission on Wednesday. One day later, Chung Shan Medical University also announced it would cancel the student’s admission. China Medical
Construction of the Ma-anshan Nuclear Power Plant in Pingtung County’s Hengchun Township (恆春) started in 1978. It began commercial operations in 1984. Since then, it has experienced several accidents, radiation pollution and fires. It was finally decommissioned on May 17 after the operating license of its No. 2 reactor expired. However, a proposed referendum to be held on Aug. 23 on restarting the reactor is potentially bringing back those risks. Four reasons are listed for holding the referendum: First, the difficulty of meeting greenhouse gas reduction targets and the inefficiency of new energy sources such as photovoltaic and wind power. Second,
RSS